4.4 Article

RAPID3 (Routine Assessment of Patient Index Data 3) Severity Categories and Response Criteria: Similar Results to DA528 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) Clinical Trial of Certolizumab Pegol

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Joint Counts to Assess Rheumatoid Arthritis for Clinical Research and Usual Clinical Care: Advantages and Limitations

Tuulikki Sokka et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2009)

Article Rheumatology

Laboratory Tests to Assess Patients with Rheumatoid Arthritis: Advantages and Limitations

Theodore Pincus et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2009)